Edwards Acquires JenaValve and Endotronix, Expands into Aortic Regurgitation and Heart Failure
CardiacWire
JULY 28, 2024
Edwards Lifesciences is going all-in on structural heart and heart failure, acquiring aortic valve-maker JenaValve Technology and implantable heart failure monitor company Endotronix for $1.2B and up to $445M in milestone payments.
Let's personalize your content